Standardization Arrives for Neoadjuvant Trials in Melanoma

The new recommendations will help standardize  neoadjuvant clinical trial methodology and develop a path for regulatory review and approval of neoadjuvant therapies in melanoma.

Source: CancerNetwork - August 6, 2019 Category: Cancer & Oncology Authors: Christina Bennett, MS Source Type: news